Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

BACKGROUND: Receptor selectivity of sodium-glucose cotransporter-2 inhibitors (SGLT2i) varies greatly between agents. The overall improvement of cardiovascular (CV) outcomes in heart failure (HF) patients varies between trials. We, therefore, evaluated the comparative efficacy of individual SGLT2i a...

Descripción completa

Detalles Bibliográficos
Autores principales: Täger, Tobias, Frankenstein, Lutz, Atar, Dan, Agewall, Stefan, Frey, Norbert, Grundtvig, Morten, Clark, Andrew L., Cleland, John G. F., Fröhlich, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971161/
https://www.ncbi.nlm.nih.gov/pubmed/34498169
http://dx.doi.org/10.1007/s00392-021-01913-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971161/
https://www.ncbi.nlm.nih.gov/pubmed/34498169
http://dx.doi.org/10.1007/s00392-021-01913-z

Ejemplares similares